Global Organoids and Spheroids Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Page: 103

Published Date: 15 Jan 2022

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Product Tags

Description

The Organoids and Spheroids market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Organoids and Spheroids market size is estimated to be worth US$  million in 2021 and is forecast to a readjusted size of USD  million by 2028 with a CAGR of  % during review period. Biotechnology and Pharmaceutical Industries accounting for  % of the Organoids and Spheroids global market in 2021, is projected to value USD  million by 2028, growing at a  % CAGR in next six years. While by Organoids Type segment is altered to a  % CAGR between 2022 and 2028.

Global key companies of Organoids and Spheroids include Merck KGaA, ATCC, Corning Incorporated, Greiner Bio-One(Greiner Group AG), and AMS Biotechnology (Europe) Limited, etc. In terms of revenue, the global top four players hold a share over  % in 2021.

Market segmentation
Organoids and Spheroids market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    by Organoids Type
        Neural Organoids
        Hepatic Organoids
        Intestinal Organoids
        Others
    by Spheroids Type
        Multicellular Tumor Spheroids (MCTS)
        Neurospheres
        Mammospheres
        Hepatospheres
        Embryoid Bodies

Market segment by Application, can be divided into
    Biotechnology and Pharmaceutical Industries
    Academic and Research Institutes
    Hospitals and Diagnostic Centers

Market segment by players, this report covers
    Merck KGaA
    ATCC
    Corning Incorporated
    Greiner Bio-One(Greiner Group AG)
    AMS Biotechnology (Europe) Limited
    Lonza
    Hubrecht Organoid Technology (HUB)
    3D Biomatrix
    3D Biotek LLC
    Cellesce Ltd.
    Prellis Biologics
    STEMCELL Technologies Inc.
    Thermo Fisher Scientific Inc.

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Organoids and Spheroids product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Organoids and Spheroids, with revenue, gross margin and global market share of Organoids and Spheroids from 2019 to 2022.
Chapter 3, the Organoids and Spheroids competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Organoids and Spheroids market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Organoids and Spheroids research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Organoids and Spheroids
    1.2 Classification of Organoids and Spheroids by Type
        1.2.1 Overview: Global Organoids and Spheroids Market Size by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Global Organoids and Spheroids Revenue Market Share by Type in 2021
        1.2.3 Neural Organoids
        1.2.4 Hepatic Organoids
        1.2.5 Intestinal Organoids
        1.2.6 Others
    1.3 Global Organoids and Spheroids Market by Application
        1.3.1 Overview: Global Organoids and Spheroids Market Size by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Biotechnology and Pharmaceutical Industries
        1.3.3 Academic and Research Institutes
        1.3.4 Hospitals and Diagnostic Centers
    1.4 Global Organoids and Spheroids Market Size & Forecast
    1.5 Global Organoids and Spheroids Market Size and Forecast by Region
        1.5.1 Global Organoids and Spheroids Market Size by Region: 2017 VS 2021 VS 2028
        1.5.2 Global Organoids and Spheroids Market Size by Region, (2017-2022)
        1.5.3 North America Organoids and Spheroids Market Size and Prospect (2017-2028)
        1.5.4 Europe Organoids and Spheroids Market Size and Prospect (2017-2028)
        1.5.5 Asia-Pacific Organoids and Spheroids Market Size and Prospect (2017-2028)
        1.5.6 South America Organoids and Spheroids Market Size and Prospect (2017-2028)
        1.5.7 Middle East and Africa Organoids and Spheroids Market Size and Prospect (2017-2028)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Organoids and Spheroids Market Drivers
        1.6.2 Organoids and Spheroids Market Restraints
        1.6.3 Organoids and Spheroids Trends Analysis

2 Company Profiles
    2.1 Merck KGaA
        2.1.1 Merck KGaA Details
        2.1.2 Merck KGaA Major Business
        2.1.3 Merck KGaA Organoids and Spheroids Product and Solutions
        2.1.4 Merck KGaA Organoids and Spheroids Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.1.5 Merck KGaA Recent Developments and Future Plans
    2.2 ATCC
        2.2.1 ATCC Details
        2.2.2 ATCC Major Business
        2.2.3 ATCC Organoids and Spheroids Product and Solutions
        2.2.4 ATCC Organoids and Spheroids Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.2.5 ATCC Recent Developments and Future Plans
    2.3 Corning Incorporated
        2.3.1 Corning Incorporated Details
        2.3.2 Corning Incorporated Major Business
        2.3.3 Corning Incorporated Organoids and Spheroids Product and Solutions
        2.3.4 Corning Incorporated Organoids and Spheroids Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.3.5 Corning Incorporated Recent Developments and Future Plans
    2.4 Greiner Bio-One(Greiner Group AG)
        2.4.1 Greiner Bio-One(Greiner Group AG) Details
        2.4.2 Greiner Bio-One(Greiner Group AG) Major Business
        2.4.3 Greiner Bio-One(Greiner Group AG) Organoids and Spheroids Product and Solutions
        2.4.4 Greiner Bio-One(Greiner Group AG) Organoids and Spheroids Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.4.5 Greiner Bio-One(Greiner Group AG) Recent Developments and Future Plans
    2.5 AMS Biotechnology (Europe) Limited
        2.5.1 AMS Biotechnology (Europe) Limited Details
        2.5.2 AMS Biotechnology (Europe) Limited Major Business
        2.5.3 AMS Biotechnology (Europe) Limited Organoids and Spheroids Product and Solutions
        2.5.4 AMS Biotechnology (Europe) Limited Organoids and Spheroids Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.5.5 AMS Biotechnology (Europe) Limited Recent Developments and Future Plans
    2.6 Lonza
        2.6.1 Lonza Details
        2.6.2 Lonza Major Business
        2.6.3 Lonza Organoids and Spheroids Product and Solutions
        2.6.4 Lonza Organoids and Spheroids Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.6.5 Lonza Recent Developments and Future Plans
    2.7 Hubrecht Organoid Technology (HUB)
        2.7.1 Hubrecht Organoid Technology (HUB) Details
        2.7.2 Hubrecht Organoid Technology (HUB) Major Business
        2.7.3 Hubrecht Organoid Technology (HUB) Organoids and Spheroids Product and Solutions
        2.7.4 Hubrecht Organoid Technology (HUB) Organoids and Spheroids Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.7.5 Hubrecht Organoid Technology (HUB) Recent Developments and Future Plans
    2.8 3D Biomatrix
        2.8.1 3D Biomatrix Details
        2.8.2 3D Biomatrix Major Business
        2.8.3 3D Biomatrix Organoids and Spheroids Product and Solutions
        2.8.4 3D Biomatrix Organoids and Spheroids Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.8.5 3D Biomatrix Recent Developments and Future Plans
    2.9 3D Biotek LLC
        2.9.1 3D Biotek LLC Details
        2.9.2 3D Biotek LLC Major Business
        2.9.3 3D Biotek LLC Organoids and Spheroids Product and Solutions
        2.9.4 3D Biotek LLC Organoids and Spheroids Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.9.5 3D Biotek LLC Recent Developments and Future Plans
    2.10 Cellesce Ltd.
        2.10.1 Cellesce Ltd. Details
        2.10.2 Cellesce Ltd. Major Business
        2.10.3 Cellesce Ltd. Organoids and Spheroids Product and Solutions
        2.10.4 Cellesce Ltd. Organoids and Spheroids Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.10.5 Cellesce Ltd. Recent Developments and Future Plans
    2.11 Prellis Biologics
        2.11.1 Prellis Biologics Details
        2.11.2 Prellis Biologics Major Business
        2.11.3 Prellis Biologics Organoids and Spheroids Product and Solutions
        2.11.4 Prellis Biologics Organoids and Spheroids Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.11.5 Prellis Biologics Recent Developments and Future Plans
    2.12 STEMCELL Technologies Inc.
        2.12.1 STEMCELL Technologies Inc. Details
        2.12.2 STEMCELL Technologies Inc. Major Business
        2.12.3 STEMCELL Technologies Inc. Organoids and Spheroids Product and Solutions
        2.12.4 STEMCELL Technologies Inc. Organoids and Spheroids Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.12.5 STEMCELL Technologies Inc. Recent Developments and Future Plans
    2.13 Thermo Fisher Scientific Inc.
        2.13.1 Thermo Fisher Scientific Inc. Details
        2.13.2 Thermo Fisher Scientific Inc. Major Business
        2.13.3 Thermo Fisher Scientific Inc. Organoids and Spheroids Product and Solutions
        2.13.4 Thermo Fisher Scientific Inc. Organoids and Spheroids Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.13.5 Thermo Fisher Scientific Inc. Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Organoids and Spheroids Revenue and Share by Players (2019, 2020, 2021, and 2022)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Organoids and Spheroids Players Market Share in 2021
        3.2.2 Top 10 Organoids and Spheroids Players Market Share in 2021
        3.2.3 Market Competition Trend
    3.3 Organoids and Spheroids Players Head Office, Products and Services Provided
    3.4 Organoids and Spheroids Mergers & Acquisitions
    3.5 Organoids and Spheroids New Entrants and Expansion Plans

4 Market Size Segment by Type
    4.1 Global Organoids and Spheroids Revenue and Market Share by Type (2017-2022)
    4.2 Global Organoids and Spheroids Market Forecast by Type (2023-2028)

5 Market Size Segment by Application
    5.1 Global Organoids and Spheroids Revenue Market Share by Application (2017-2022)
    5.2 Global Organoids and Spheroids Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application
    6.1 North America Organoids and Spheroids Revenue by Type (2017-2028)
    6.2 North America Organoids and Spheroids Revenue by Application (2017-2028)
    6.3 North America Organoids and Spheroids Market Size by Country
        6.3.1 North America Organoids and Spheroids Revenue by Country (2017-2028)
        6.3.2 United States Organoids and Spheroids Market Size and Forecast (2017-2028)
        6.3.3 Canada Organoids and Spheroids Market Size and Forecast (2017-2028)
        6.3.4 Mexico Organoids and Spheroids Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application
    7.1 Europe Organoids and Spheroids Revenue by Type (2017-2028)
    7.2 Europe Organoids and Spheroids Revenue by Application (2017-2028)
    7.3 Europe Organoids and Spheroids Market Size by Country
        7.3.1 Europe Organoids and Spheroids Revenue by Country (2017-2028)
        7.3.2 Germany Organoids and Spheroids Market Size and Forecast (2017-2028)
        7.3.3 France Organoids and Spheroids Market Size and Forecast (2017-2028)
        7.3.4 United Kingdom Organoids and Spheroids Market Size and Forecast (2017-2028)
        7.3.5 Russia Organoids and Spheroids Market Size and Forecast (2017-2028)
        7.3.6 Italy Organoids and Spheroids Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Organoids and Spheroids Revenue by Type (2017-2028)
    8.2 Asia-Pacific Organoids and Spheroids Revenue by Application (2017-2028)
    8.3 Asia-Pacific Organoids and Spheroids Market Size by Region
        8.3.1 Asia-Pacific Organoids and Spheroids Revenue by Region (2017-2028)
        8.3.2 China Organoids and Spheroids Market Size and Forecast (2017-2028)
        8.3.3 Japan Organoids and Spheroids Market Size and Forecast (2017-2028)
        8.3.4 South Korea Organoids and Spheroids Market Size and Forecast (2017-2028)
        8.3.5 India Organoids and Spheroids Market Size and Forecast (2017-2028)
        8.3.6 Southeast Asia Organoids and Spheroids Market Size and Forecast (2017-2028)
        8.3.7 Australia Organoids and Spheroids Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application
    9.1 South America Organoids and Spheroids Revenue by Type (2017-2028)
    9.2 South America Organoids and Spheroids Revenue by Application (2017-2028)
    9.3 South America Organoids and Spheroids Market Size by Country
        9.3.1 South America Organoids and Spheroids Revenue by Country (2017-2028)
        9.3.2 Brazil Organoids and Spheroids Market Size and Forecast (2017-2028)
        9.3.3 Argentina Organoids and Spheroids Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Organoids and Spheroids Revenue by Type (2017-2028)
    10.2 Middle East & Africa Organoids and Spheroids Revenue by Application (2017-2028)
    10.3 Middle East & Africa Organoids and Spheroids Market Size by Country
        10.3.1 Middle East & Africa Organoids and Spheroids Revenue by Country (2017-2028)
        10.3.2 Turkey Organoids and Spheroids Market Size and Forecast (2017-2028)
        10.3.3 Saudi Arabia Organoids and Spheroids Market Size and Forecast (2017-2028)
        10.3.4 UAE Organoids and Spheroids Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Organoids and Spheroids Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
    Table 2. Global Organoids and Spheroids Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
    Table 3. Global Market Organoids and Spheroids Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
    Table 4. Global Organoids and Spheroids Revenue (USD Million) by Region (2017-2022)
    Table 5. Global Organoids and Spheroids Revenue Market Share by Region (2023-2028)
    Table 6. Merck KGaA Corporate Information, Head Office, and Major Competitors
    Table 7. Merck KGaA Major Business
    Table 8. Merck KGaA Organoids and Spheroids Product and Solutions
    Table 9. Merck KGaA Organoids and Spheroids Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 10. ATCC Corporate Information, Head Office, and Major Competitors
    Table 11. ATCC Major Business
    Table 12. ATCC Organoids and Spheroids Product and Solutions
    Table 13. ATCC Organoids and Spheroids Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 14. Corning Incorporated Corporate Information, Head Office, and Major Competitors
    Table 15. Corning Incorporated Major Business
    Table 16. Corning Incorporated Organoids and Spheroids Product and Solutions
    Table 17. Corning Incorporated Organoids and Spheroids Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 18. Greiner Bio-One(Greiner Group AG) Corporate Information, Head Office, and Major Competitors
    Table 19. Greiner Bio-One(Greiner Group AG) Major Business
    Table 20. Greiner Bio-One(Greiner Group AG) Organoids and Spheroids Product and Solutions
    Table 21. Greiner Bio-One(Greiner Group AG) Organoids and Spheroids Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 22. AMS Biotechnology (Europe) Limited Corporate Information, Head Office, and Major Competitors
    Table 23. AMS Biotechnology (Europe) Limited Major Business
    Table 24. AMS Biotechnology (Europe) Limited Organoids and Spheroids Product and Solutions
    Table 25. AMS Biotechnology (Europe) Limited Organoids and Spheroids Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 26. Lonza Corporate Information, Head Office, and Major Competitors
    Table 27. Lonza Major Business
    Table 28. Lonza Organoids and Spheroids Product and Solutions
    Table 29. Lonza Organoids and Spheroids Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 30. Hubrecht Organoid Technology (HUB) Corporate Information, Head Office, and Major Competitors
    Table 31. Hubrecht Organoid Technology (HUB) Major Business
    Table 32. Hubrecht Organoid Technology (HUB) Organoids and Spheroids Product and Solutions
    Table 33. Hubrecht Organoid Technology (HUB) Organoids and Spheroids Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 34. 3D Biomatrix Corporate Information, Head Office, and Major Competitors
    Table 35. 3D Biomatrix Major Business
    Table 36. 3D Biomatrix Organoids and Spheroids Product and Solutions
    Table 37. 3D Biomatrix Organoids and Spheroids Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 38. 3D Biotek LLC Corporate Information, Head Office, and Major Competitors
    Table 39. 3D Biotek LLC Major Business
    Table 40. 3D Biotek LLC Organoids and Spheroids Product and Solutions
    Table 41. 3D Biotek LLC Organoids and Spheroids Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 42. Cellesce Ltd. Corporate Information, Head Office, and Major Competitors
    Table 43. Cellesce Ltd. Major Business
    Table 44. Cellesce Ltd. Organoids and Spheroids Product and Solutions
    Table 45. Cellesce Ltd. Organoids and Spheroids Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 46. Prellis Biologics Corporate Information, Head Office, and Major Competitors
    Table 47. Prellis Biologics Major Business
    Table 48. Prellis Biologics Organoids and Spheroids Product and Solutions
    Table 49. Prellis Biologics Organoids and Spheroids Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 50. STEMCELL Technologies Inc. Corporate Information, Head Office, and Major Competitors
    Table 51. STEMCELL Technologies Inc. Major Business
    Table 52. STEMCELL Technologies Inc. Organoids and Spheroids Product and Solutions
    Table 53. STEMCELL Technologies Inc. Organoids and Spheroids Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 54. Thermo Fisher Scientific Inc. Corporate Information, Head Office, and Major Competitors
    Table 55. Thermo Fisher Scientific Inc. Major Business
    Table 56. Thermo Fisher Scientific Inc. Organoids and Spheroids Product and Solutions
    Table 57. Thermo Fisher Scientific Inc. Organoids and Spheroids Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 58. Global Organoids and Spheroids Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
    Table 59. Global Organoids and Spheroids Revenue Share by Players (2019, 2020, 2021, and 2022)
    Table 60. Breakdown of Organoids and Spheroids by Company Type (Tier 1, Tier 2 and Tier 3)
    Table 61. Organoids and Spheroids Players Head Office, Products and Services Provided
    Table 62. Organoids and Spheroids Mergers & Acquisitions in the Past Five Years
    Table 63. Organoids and Spheroids New Entrants and Expansion Plans
    Table 64. Global Organoids and Spheroids Revenue (USD Million) by Type (2017-2022)
    Table 65. Global Organoids and Spheroids Revenue Share by Type (2017-2022)
    Table 66. Global Organoids and Spheroids Revenue Forecast by Type (2023-2028)
    Table 67. Global Organoids and Spheroids Revenue by Application (2017-2022)
    Table 68. Global Organoids and Spheroids Revenue Forecast by Application (2023-2028)
    Table 69. North America Organoids and Spheroids Revenue by Type (2017-2022) & (USD Million)
    Table 70. North America Organoids and Spheroids Revenue by Type (2023-2028) & (USD Million)
    Table 71. North America Organoids and Spheroids Revenue by Application (2017-2022) & (USD Million)
    Table 72. North America Organoids and Spheroids Revenue by Application (2023-2028) & (USD Million)
    Table 73. North America Organoids and Spheroids Revenue by Country (2017-2022) & (USD Million)
    Table 74. North America Organoids and Spheroids Revenue by Country (2023-2028) & (USD Million)
    Table 75. Europe Organoids and Spheroids Revenue by Type (2017-2022) & (USD Million)
    Table 76. Europe Organoids and Spheroids Revenue by Type (2023-2028) & (USD Million)
    Table 77. Europe Organoids and Spheroids Revenue by Application (2017-2022) & (USD Million)
    Table 78. Europe Organoids and Spheroids Revenue by Application (2023-2028) & (USD Million)
    Table 79. Europe Organoids and Spheroids Revenue by Country (2017-2022) & (USD Million)
    Table 80. Europe Organoids and Spheroids Revenue by Country (2023-2028) & (USD Million)
    Table 81. Asia-Pacific Organoids and Spheroids Revenue by Type (2017-2022) & (USD Million)
    Table 82. Asia-Pacific Organoids and Spheroids Revenue by Type (2023-2028) & (USD Million)
    Table 83. Asia-Pacific Organoids and Spheroids Revenue by Application (2017-2022) & (USD Million)
    Table 84. Asia-Pacific Organoids and Spheroids Revenue by Application (2023-2028) & (USD Million)
    Table 85. Asia-Pacific Organoids and Spheroids Revenue by Region (2017-2022) & (USD Million)
    Table 86. Asia-Pacific Organoids and Spheroids Revenue by Region (2023-2028) & (USD Million)
    Table 87. South America Organoids and Spheroids Revenue by Type (2017-2022) & (USD Million)
    Table 88. South America Organoids and Spheroids Revenue by Type (2023-2028) & (USD Million)
    Table 89. South America Organoids and Spheroids Revenue by Application (2017-2022) & (USD Million)
    Table 90. South America Organoids and Spheroids Revenue by Application (2023-2028) & (USD Million)
    Table 91. South America Organoids and Spheroids Revenue by Country (2017-2022) & (USD Million)
    Table 92. South America Organoids and Spheroids Revenue by Country (2023-2028) & (USD Million)
    Table 93. Middle East & Africa Organoids and Spheroids Revenue by Type (2017-2022) & (USD Million)
    Table 94. Middle East & Africa Organoids and Spheroids Revenue by Type (2023-2028) & (USD Million)
    Table 95. Middle East & Africa Organoids and Spheroids Revenue by Application (2017-2022) & (USD Million)
    Table 96. Middle East & Africa Organoids and Spheroids Revenue by Application (2023-2028) & (USD Million)
    Table 97. Middle East & Africa Organoids and Spheroids Revenue by Country (2017-2022) & (USD Million)
    Table 98. Middle East & Africa Organoids and Spheroids Revenue by Country (2023-2028) & (USD Million)
List of Figures
    Figure 1. Organoids and Spheroids Picture
    Figure 2. Global Organoids and Spheroids Revenue Market Share by Type in 2021
    Figure 3. Neural Organoids
    Figure 4. Hepatic Organoids
    Figure 5. Intestinal Organoids
    Figure 6. Others
    Figure 7. Organoids and Spheroids Revenue Market Share by Application in 2021
    Figure 8. Biotechnology and Pharmaceutical Industries Picture
    Figure 9. Academic and Research Institutes Picture
    Figure 10. Hospitals and Diagnostic Centers Picture
    Figure 11. Global Organoids and Spheroids Market Size, (USD Million): 2017 VS 2021 VS 2028
    Figure 12. Global Organoids and Spheroids Revenue and Forecast (2017-2028) & (USD Million)
    Figure 13. Global Organoids and Spheroids Revenue Market Share by Region (2017-2028)
    Figure 14. Global Organoids and Spheroids Revenue Market Share by Region in 2021
    Figure 15. North America Organoids and Spheroids Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 16. Europe Organoids and Spheroids Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 17. Asia-Pacific Organoids and Spheroids Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 18. South America Organoids and Spheroids Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 19. Middle East and Africa Organoids and Spheroids Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 20. Organoids and Spheroids Market Drivers
    Figure 21. Organoids and Spheroids Market Restraints
    Figure 22. Organoids and Spheroids Market Trends
    Figure 23. Merck KGaA Recent Developments and Future Plans
    Figure 24. ATCC Recent Developments and Future Plans
    Figure 25. Corning Incorporated Recent Developments and Future Plans
    Figure 26. Greiner Bio-One(Greiner Group AG) Recent Developments and Future Plans
    Figure 27. AMS Biotechnology (Europe) Limited Recent Developments and Future Plans
    Figure 28. Lonza Recent Developments and Future Plans
    Figure 29. Hubrecht Organoid Technology (HUB) Recent Developments and Future Plans
    Figure 30. 3D Biomatrix Recent Developments and Future Plans
    Figure 31. 3D Biotek LLC Recent Developments and Future Plans
    Figure 32. Cellesce Ltd. Recent Developments and Future Plans
    Figure 33. Prellis Biologics Recent Developments and Future Plans
    Figure 34. STEMCELL Technologies Inc. Recent Developments and Future Plans
    Figure 35. Thermo Fisher Scientific Inc. Recent Developments and Future Plans
    Figure 36. Global Organoids and Spheroids Revenue Share by Players in 2021
    Figure 37. Organoids and Spheroids Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
    Figure 38. Global Top 3 Players Organoids and Spheroids Revenue Market Share in 2021
    Figure 39. Global Top 10 Players Organoids and Spheroids Revenue Market Share in 2021
    Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
    Figure 41. Global Organoids and Spheroids Revenue Share by Type in 2021
    Figure 42. Global Organoids and Spheroids Market Share Forecast by Type (2023-2028)
    Figure 43. Global Organoids and Spheroids Revenue Share by Application in 2021
    Figure 44. Global Organoids and Spheroids Market Share Forecast by Application (2023-2028)
    Figure 45. North America Organoids and Spheroids Sales Market Share by Type (2017-2028)
    Figure 46. North America Organoids and Spheroids Sales Market Share by Application (2017-2028)
    Figure 47. North America Organoids and Spheroids Revenue Market Share by Country (2017-2028)
    Figure 48. United States Organoids and Spheroids Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 49. Canada Organoids and Spheroids Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 50. Mexico Organoids and Spheroids Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 51. Europe Organoids and Spheroids Sales Market Share by Type (2017-2028)
    Figure 52. Europe Organoids and Spheroids Sales Market Share by Application (2017-2028)
    Figure 53. Europe Organoids and Spheroids Revenue Market Share by Country (2017-2028)
    Figure 54. Germany Organoids and Spheroids Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 55. France Organoids and Spheroids Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 56. United Kingdom Organoids and Spheroids Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 57. Russia Organoids and Spheroids Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 58. Italy Organoids and Spheroids Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 59. Asia-Pacific Organoids and Spheroids Sales Market Share by Type (2017-2028)
    Figure 60. Asia-Pacific Organoids and Spheroids Sales Market Share by Application (2017-2028)
    Figure 61. Asia-Pacific Organoids and Spheroids Revenue Market Share by Region (2017-2028)
    Figure 62. China Organoids and Spheroids Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 63. Japan Organoids and Spheroids Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 64. South Korea Organoids and Spheroids Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 65. India Organoids and Spheroids Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 66. Southeast Asia Organoids and Spheroids Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 67. Australia Organoids and Spheroids Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 68. South America Organoids and Spheroids Sales Market Share by Type (2017-2028)
    Figure 69. South America Organoids and Spheroids Sales Market Share by Application (2017-2028)
    Figure 70. South America Organoids and Spheroids Revenue Market Share by Country (2017-2028)
    Figure 71. Brazil Organoids and Spheroids Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 72. Argentina Organoids and Spheroids Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 73. Middle East and Africa Organoids and Spheroids Sales Market Share by Type (2017-2028)
    Figure 74. Middle East and Africa Organoids and Spheroids Sales Market Share by Application (2017-2028)
    Figure 75. Middle East and Africa Organoids and Spheroids Revenue Market Share by Country (2017-2028)
    Figure 76. Turkey Organoids and Spheroids Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 77. Saudi Arabia Organoids and Spheroids Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 78. UAE Organoids and Spheroids Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 79. Methodology
    Figure 80. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Merck KGaA
ATCC
Corning Incorporated
Greiner Bio-One(Greiner Group AG)
AMS Biotechnology (Europe) Limited
Lonza
Hubrecht Organoid Technology (HUB)
3D Biomatrix
3D Biotek LLC
Cellesce Ltd.
Prellis Biologics
STEMCELL Technologies Inc.
Thermo Fisher Scientific Inc.

Product Tags

organoids spheroids

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>